Member Info for geeforce2010

But we fell from 3.5/4p to 1p before rise, so we are just back to that now with a small increase but the company a lot further down the road. IQAI with the 2 companies are set up to have a excellent 2020 after all the hard work done this year, FDA approval, IB grant funding and other products coming on stream, sales should start to move quickly in 2020.
Finally Trevor Brown and David Smith payout on sale of company which I believe can be from September 2020 onwards.

Blue , are you licensed to give investment advice? You only post on this stock and negative because before you buy back in you want it as cheap as possible and punters selling at a loss you appear to encourage this so you can buy back cheaper?
This company has today a fantastic year for what they have achieved,yes I am disappointed how share price has fallen last 4 weeks but punters are chasing other stocks and drop has nothing to do with company, agree with Technickdo your research and if happy buy and hold.

You and taff not the same poster? Similar posting styles and stocks, both negative posts currently !

Times mentions Japan, RNS mentions Japan, so replying to that article directly.

Validates IB tech, $2.75mill grant money will be used for this development, 2020 should be a very Strong year for IQAI, raised £775,000 post June 19 and had current assets of £400k at period end. Therefore no need to raise funds until 2021, loss to 6months 30th June 19 £140k.

Shareholders should take a 12-18 view and should be richly rewarded on sale of IQAI, TB in 70s, DS will be with IQAI 2 years next August so from this time next year we could see a sale, also lot of newsflow will also drive share price up as well.

£4.8milion reasons!

Strong buy!

Are now selling out at a loss, lol, big gains coming if you can be bothered to hold the stock for 22 months!

Plenty of sellers/traders out there! Price holding up but need news to drag twitter pumpers back in!

It’s exciting times for iqai shareholders but let’s not get to excited just yet from years of experience witnessing huge jumps like Fridays there is usually a slight pullback however I do feel an fda approval is a special event for any healthcare stock so hopefully we will power on through the sellers.

IB StoneChecker® analysis software is in the final stages of FDA clearance for distribution in the US and will also be added to the CorTechs' portfolio, internationally. StoneChecker provides a critical tool in the management of kidney stone treatment. The software analyses 32 different standardised parameters to distinguish kidney stone size, location and composition to provide conclusive data that determines if lithotripsy is an effective treatment option.

1 deal all ready in place lol, most people have churned those big gains by now my guess.

Cortech all ready have agreement to sell Stonechecker but not exclusive, give them some time, DS excellent CEO, look at RNSs since June, very impressive!

Tern went from 2p to 58p last summer, so who knows !

Real gains over next 12 months, going to be stellar!

Patience is the key, think they will be buying a lot higher sooner rather than later hopefully!

MMS will drag it down on small sells which is what is happening but buying will push it back up very quickly.

people will sell after results, which was fine but 3 months since FDA approval was imminent people will sell and play elsewhere, so agree could get choppy until FDA approval arrives but hold to many to trade!

Still holding but will have to speak to DS before I go away in October if FDA not received.

Good read! IAQI, very low expenditure to 30/6/19 and small loss, next 12 months very exciting, FDA approval soon! hopefully DS will do another proactive interview, think quite a bit more news will come before Xmas.